Chemoinformaics analysis of 1-isobutyl-1,2,3,4-tetrahydro-beta-carboline
| Molecular Weight | 274.272 | nRot | 3 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 15 |
| Exact Molecular Weight | 274.084 | nRing | 3 |
| Solubility: LogS | -3.843 | nHRing | 1 |
| Solubility: LogP | 3.057 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 15 |
| nHA | 5 | APOL | 38.3951 |
| nHD | 1 | BPOL | 20.9889 |
| QED | 0.793 |
| Synth | 2.382 |
| Natural Product Likeliness | 1.197 |
| NR-PPAR-gamma | 0.721 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.976 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -4.806 |
| MDCK | 0.0000306 |
| BBB | 0.114 |
| PPB | 0.868531 |
| VDSS | 0.796 |
| FU | 0.176304 |
| CYP1A2-inh | 0.947 |
| CYP1A2-sub | 0.976 |
| CYP2c19-inh | 0.674 |
| CYP2c19-sub | 0.868 |
| CYP2c9-inh | 0.592 |
| CYP2c9-sub | 0.896 |
| CYP2d6-inh | 0.18 |
| CYP2d6-sub | 0.865 |
| CYP3a4-inh | 0.433 |
| CYP3a4-sub | 0.599 |
| CL | 6.124 |
| T12 | 0.672 |
| hERG | 0.034 |
| Ames | 0.542 |
| ROA | 0.728 |
| SkinSen | 0.651 |
| Carcinogencity | 0.573 |
| EI | 0.703 |
| Respiratory | 0.221 |
| NR-Aromatase | 0.85 |
| Antiviral | Yes |
| Prediction | 0.729739 |